$SRPT $NVS developing vaccine using AAV. What's the risk of this vaccine being reactive or be a leading vaccine?

- still investigating
- "strongly" believes no AAV method should be used
- $NVS has interest to not take 30 years of research away
- $JNJ's adenovirus is non-reactive